{"title":"用于药物发现应用的配体-寡核苷酸缀合物的合成方法的发展。","authors":"Takashi Osawa","doi":"10.1248/cpb.c25-00387","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, oligonucleotide-based drug discovery has attracted considerable amounts of attention. As oligonucleotide therapeutics have evolved into practical use, research into the development of functional artificial nucleic acids has been vigorously conducted worldwide. However, the synthesis of artificial nucleic acids generally requires long sequences from starting materials; hence, structurally optimizing oligonucleotide therapeutics is extremely difficult. In response to this challenge, we have been developing reactions that use oligonucleotides as starting materials. As a part of this work, we focused on ligand-oligonucleotide conjugates because the conjugates of functional ligands and oligonucleotides have attracted attention as drug-delivery systems that improve the efficacies of oligonucleotide therapeutics; they are also DNA-encoded-library-based drug-discovery tools. In this review, we broadly introduce our research into ligand-oligonucleotide conjugates.</p>","PeriodicalId":9773,"journal":{"name":"Chemical & pharmaceutical bulletin","volume":"73 9","pages":"762-771"},"PeriodicalIF":1.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Developing Methods for the Synthesis of Ligand-Oligonucleotide Conjugates for Drug Discovery Applications.\",\"authors\":\"Takashi Osawa\",\"doi\":\"10.1248/cpb.c25-00387\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Recently, oligonucleotide-based drug discovery has attracted considerable amounts of attention. As oligonucleotide therapeutics have evolved into practical use, research into the development of functional artificial nucleic acids has been vigorously conducted worldwide. However, the synthesis of artificial nucleic acids generally requires long sequences from starting materials; hence, structurally optimizing oligonucleotide therapeutics is extremely difficult. In response to this challenge, we have been developing reactions that use oligonucleotides as starting materials. As a part of this work, we focused on ligand-oligonucleotide conjugates because the conjugates of functional ligands and oligonucleotides have attracted attention as drug-delivery systems that improve the efficacies of oligonucleotide therapeutics; they are also DNA-encoded-library-based drug-discovery tools. In this review, we broadly introduce our research into ligand-oligonucleotide conjugates.</p>\",\"PeriodicalId\":9773,\"journal\":{\"name\":\"Chemical & pharmaceutical bulletin\",\"volume\":\"73 9\",\"pages\":\"762-771\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemical & pharmaceutical bulletin\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1248/cpb.c25-00387\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical & pharmaceutical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/cpb.c25-00387","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Developing Methods for the Synthesis of Ligand-Oligonucleotide Conjugates for Drug Discovery Applications.
Recently, oligonucleotide-based drug discovery has attracted considerable amounts of attention. As oligonucleotide therapeutics have evolved into practical use, research into the development of functional artificial nucleic acids has been vigorously conducted worldwide. However, the synthesis of artificial nucleic acids generally requires long sequences from starting materials; hence, structurally optimizing oligonucleotide therapeutics is extremely difficult. In response to this challenge, we have been developing reactions that use oligonucleotides as starting materials. As a part of this work, we focused on ligand-oligonucleotide conjugates because the conjugates of functional ligands and oligonucleotides have attracted attention as drug-delivery systems that improve the efficacies of oligonucleotide therapeutics; they are also DNA-encoded-library-based drug-discovery tools. In this review, we broadly introduce our research into ligand-oligonucleotide conjugates.
期刊介绍:
The CPB covers various chemical topics in the pharmaceutical and health sciences fields dealing with biologically active compounds, natural products, and medicines, while BPB deals with a wide range of biological topics in the pharmaceutical and health sciences fields including scientific research from basic to clinical studies. For details of their respective scopes, please refer to the submission topic categories below.
Topics: Organic chemistry
In silico science
Inorganic chemistry
Pharmacognosy
Health statistics
Forensic science
Biochemistry
Pharmacology
Pharmaceutical care and science
Medicinal chemistry
Analytical chemistry
Physical pharmacy
Natural product chemistry
Toxicology
Environmental science
Molecular and cellular biology
Biopharmacy and pharmacokinetics
Pharmaceutical education
Chemical biology
Physical chemistry
Pharmaceutical engineering
Epidemiology
Hygiene
Regulatory science
Immunology and microbiology
Clinical pharmacy
Miscellaneous.